Aligos Therapeutics, Inc. (ALGS) Operating margin 2023–2025
Aligos Therapeutics, Inc. (ALGS) operating margin by fiscal year — reported operating income divided by reported revenue.
-4024.9%FY2025 · since FY2023: -1423.5% → -4024.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4024.9% | -1556.0 pp |
| FY2024 | -2469.0% | -1045.5 pp |
| FY2023 | -1423.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ALGS financial trends
ALGS RevenueALGS Net incomeALGS Net marginALGS Gross profitALGS Gross marginALGS Operating incomeALGS Operating cash flowALGS Free cash flowALGS Capital expendituresALGS Return on equityALGS Stock buybacksALGS Dividends paidALGS Total assetsALGS Total liabilitiesALGS Shareholders’ equityALGS overview →